AI MARKET SCANNING

Seres Therapeutics Inc

📅 Next Catalyst: Nov 04, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +0.74%
MAX GAP RECORD +13.19%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $MCRB
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 04, 2026 Earnings Release 2026-11-04 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 05, 2026 Earnings Release 2026-08-05 (BEFORE OPEN)
+7.24%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
-2.34%
Mar 12, 2026 Earnings Release 2026-03-12 (BEFORE OPEN)
+0.78%
Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN)
-0.36%
Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN)
-0.91%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+0.00%
Mar 13, 2025 Earnings Release 2025-03-13 (BEFORE OPEN)
-1.88%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.1%
Bullish Gaps (5)
Bearish Gaps (6)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $MCRB

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗